Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH
Clinical trial NCT04251065 · TERMINATED
Trial details
- NCT number
- NCT04251065
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2021-12-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.